News

heart drugs with stethoscope
Heart failure patients on quadruple medical therapy still face considerable risks

Most patients hospitalized for HFrEF are still not being prescribed quadruple medical therapy at discharge. Even those who are, researchers noted, still face a high risk of dying or returning to the hospital for heart failure-related symptoms. 

Imagers reviewing flurpiridaz F-18 (Flyrcado) myocardial perfusion PET images. Image from GE Healthcare
ASNC says PET is now the preferred nuclear imaging test for CAD

Which imaging modality is better for evaluating heart patients, PET or SPECT? After years of discussions and debates, the American Society of Nuclear Cardiology is now ready to point to PET as the No. 1 choice. “There are no clinical scenarios or patient subgroups where cardiac PET with myocardial blood flow should be excluded," the group wrote.

HighLife Transcatheter Mitral Valve Replacement (TMVR) System
TMVR device with valve-in-ring design gains key approval

HighLife's new-look TMVR technology was designed to treat a wide range of patients. The two-part implant process includes a ring and a valve that centers itself inside that ring.

Samir B. Pancholy, MD, chief interventional cardiologist, Wayne Memorial Hospital in Honesdale, Pennsylvania, discusses the differences in the business models for office based labs (OBL) vs ambulatory surgical centers (ASC) and choosing the right model cardiovascular and vascular procedures. #TCT #SCAI #OBL #ASC
Cardiologist highlights key differences between OBLs and ASCs

Current payment policies have health systems and physicians all over the country looking to learn more about these two business models. 

old woman or doctor shaking hands with patient
Patients with paradoxical low-flow, low gradient AS linked to higher mortality rate after TAVR

Patients with this specific subtype of severe aortic stenosis, which can sometimes be challenging to diagnose, face a number of additional risks.

Radiologist
Bayer: Helping Customers Sustain Patient Care Amid Market Disruptions

As radiology departments across the US continue to navigate the complexities of the current imaging market, including disruptions in supply chains and increased demand for CT contrast media, one constant remains: the need for reliable, quality supply partners to help sustain patient care. 

money dollar funding fundraising artificial intelligence AI
Artificial intelligence helps assign CPT codes for interventional radiology procedures

Translating procedures into standardized billing codes can be an arduous task, but researchers believe large language models offer an opportunity to simplify this work. 

Radiologists urge HHS secretary to overhaul US Preventive Services Task Force

Over 45 physicians, scientists and public health leaders believe a “fundamental shift” is needed to address how USPSTF develops and implements recommendations. 

The Boston Scientific Seismiq intravascular lithotripsy (IVL) system entered commercial use in the U.S. in January 2026.
IVL competition heats up as Boston Scientific enters US market

Shockwave Medical, now a part of Johnson & Johnson MedTech, sits at the top of the IVL market, but things are starting to get more competitive. Boston Scientific gained its own IVL system when it acquired Bolt Medical in 2025.

Gene editing software image from Scribe Therapeutics for its STX-1150 drug to treat LDL-C.
Coming soon: First-in-human study of gene-modifying drug for hypercholesterolemia

Gene-editing drugs have shown potential to treat a wide variety of diseases, and this will be one of the first in cardiovascular medicine to begin human trials.

healthcare surprise billing statement payment
SimonMed Imaging must reform billing practices, pay fine after settling state AG’s lawsuit

Arizona Attorney General Kris Mayes had accused the Scottsdale-based radiology group of issuing delayed refunds after allegedly using questionable upfront billing practices. 

board room table trustee directors
Key Lumexa Imaging C-suite leader resigns

Julie Szeker, the publicly traded company’s chief legal officer and corporate secretary, submitted her resignation on Jan. 12, according to an SEC filing.

Around the web

Cardiovascular Business
Heart failure patients on quadruple medical therapy still face considerable risks

Most patients hospitalized for HFrEF are still not being prescribed quadruple medical therapy at discharge. Even those who are, researchers noted, still face a high risk of dying or returning to the hospital for heart failure-related symptoms. 

Design by Adaptive Theme